Order intake rose 15.7% year-over-year, driven by Rofin and organic growth, but core business sales fell 7%, resulting in a negative EBIT. Strong backlog and improved Q2 support higher H2 sales, though full-year profitability remains out of reach. Cash flow and cost base are key focus areas.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.